Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
03/2014
03/18/2014US8673934 Anti-infective agents and/or immunomodulators used for preventive therapy following an acute cerebrovascular accident
03/18/2014US8673888 Depsipeptide for therapy of kidney cancer
03/18/2014US8673870 Combined DNA vaccine and biological modifiers for cancer therapy
03/18/2014US8673863 Glutathione-based delivery system
03/18/2014US8673862 Peptides and use thereof in the inhibition of angiotensin converting enzyme
03/18/2014US8673861 Tissue protective peptides and uses thereof
03/18/2014US8673860 Extended recombinant polypeptides and compositions comprising same
03/18/2014US8673859 GM-CSF cosmeceutical compositions and methods of use thereof
03/18/2014US8673858 Method for treating wrinkles using a paralytic peptide from the shrew Blarina brevicauda
03/18/2014US8673857 Long term potentiation with cyclic-GluR6 analogs
03/18/2014US8673856 Omega conotoxins
03/18/2014US8673854 Prophylactic agent for heart failure
03/18/2014US8673853 Method and device for repairing the larynx, trachea and other fibrocartilaginous tissues
03/18/2014US8673852 Methods of treating neuronal disorders using MNTF peptides and analogs thereof
03/18/2014US8673851 Synapse-specific proteins in glomeruli
03/18/2014US8673850 PCSK9 inhibitors and methods of use thereof
03/18/2014US8673847 Peptide based peroxidase inhibitors and methods of using same
03/18/2014US8673846 Cell proliferation-promoting peptide and use thereof
03/18/2014US8673845 Carrier peptide fragment and use thereof
03/18/2014US8673844 Method of inhibiting progression of type 1 diabetes by administering soluble CD137
03/18/2014US8673843 NMDA receptors modulators and uses thereof
03/18/2014US8673842 Polypeptoid pulmonary surfactants
03/18/2014US8673841 Oxytocin analogues
03/18/2014US8673840 Methods for growing tissue with Lopap-based pharmaceutical compositions
03/18/2014US8673636 Method for enzymatic treatment, device and kit used the same
03/18/2014US8673634 Method for the treatment of hearing loss
03/18/2014US8673632 Modulation of apolipoprotein (a) expression
03/18/2014US8673594 Methods for stimulating nervous system regeneration and repair by regulating arginase I and polyamine synthesis
03/18/2014US8673549 Molecular markers of plant embryogenesis
03/18/2014US8673366 Chemotherapeutic and prophylactic pharmaceutical compositions
03/18/2014US8673362 Therapeutic stem cell nutrient composition and uses thereof
03/18/2014US8673361 Cytokine modulating composition
03/18/2014US8673360 Compositions that enable rapid-acting and highly absorptive intranasal administration
03/18/2014US8673359 Nanoparticle compositions and methods for improved oral delivery of active agents
03/18/2014US8673338 Methods of delivering pharmaceutical agents
03/18/2014US8673335 Methods and compositions for sealing and adhering biological tissues and medical uses thereof
03/18/2014US8673323 Polymer nanofiber scaffold for a heparin / fibrin based growth factor delivery system
03/18/2014US8673319 Chimpanzee adenovirus vaccine carriers
03/18/2014US8673317 Codon-optimized polynucleotide-based vaccines against human Cytomegalovirus infection
03/18/2014US8673309 Methods for measuring high molecular weight complexes of fibrinogen with fibronectin and fibulin-1
03/18/2014US8673308 Targeting of CD8+ T-lymphocytes to treat neurodegenerative diseases
03/18/2014US8673305 Methods of treatment with antibodies against the extracellular loops of C5aR
03/18/2014US8673302 Anti-cMet antibody and its use for the detection and the diagnosis of cancer
03/18/2014US8673293 Use of modified cells for the treatment of multiple sclerosis
03/18/2014US8673288 Compositions and methods for inhibiting entry of a hepatic virus
03/18/2014US8673285 Sphingoid polyalkylamine conjugates for vaccination
03/18/2014US8673264 Injectable biomaterial
03/18/2014CA2767061C Specific binding agents of human angiopoietin-2
03/18/2014CA2740815C New uses for amino acid anticonvulsants
03/18/2014CA2691695C Glp-1-fc fusion protein formulation
03/18/2014CA2569788C Tumor specific antibody
03/18/2014CA2513936C Compositions and methods for treating skin conditions
03/18/2014CA2503346C Nucleic acid and corresponding protein entitled 24p4c12 useful in treatment and detection of cancer
03/18/2014CA2462713C Additive cytoprotective effects of two bioactive regions of pro-opiomelanocortin hormone
03/18/2014CA2355364C Streptococcus pneumoniae proteins and immunogenic fragments for vaccines
03/13/2014WO2014040076A1 Methods of treating neurological diseases
03/13/2014WO2014040074A2 Compositions and methods for treating cutaneous scarring
03/13/2014WO2014040008A1 Relaxin-like peptides and uses thereof
03/13/2014WO2014039987A2 Treatment of disease using inter-alpha inhibitor proteins
03/13/2014WO2014039908A1 Methods and compositions for regenerating hair cells and/or supporting cells
03/13/2014WO2014039733A1 Methods and compositions for detecting, imaging, and treating small cell lung cancer utilizing post-translationally modified residues and higher molecular weight antigenic complexes in proteins
03/13/2014WO2014039712A1 Patient reported outcome instrument
03/13/2014WO2014039504A1 Bolaamphiphilic compounds, compositions and uses thereof
03/13/2014WO2014039501A1 Bolaamphiphilic compounds, compositions and uses thereof
03/13/2014WO2014039436A1 Staphylococcus haemolyticus prophage φsh2 endolysin is lytic for staphylococcus aureus
03/13/2014WO2014039223A1 Diagnosis and treatment of aspirin-exacerbated respiratory disease (aerd)
03/13/2014WO2014039074A2 Therapeutic compositions and related methods
03/13/2014WO2014039014A1 Peptides and their uses
03/13/2014WO2014039013A1 Tetrabranched peptides and analogues as a new class of antimicrobials and their preparation thereof
03/13/2014WO2014038823A1 Composition comprising grim-19 as active ingredient for preventing or treating obesity or lipid-related metabolic diseases
03/13/2014WO2014038168A1 Functional substance, method for permeating bioactivating agent and functional substance into living body, functional substance-dispersing device, and air cleaner
03/13/2014WO2014037952A1 Individualized immunomodulation therapy for neurodegenerative disorders, cns injury and age-related dementia
03/13/2014WO2014037881A1 Compositions and methods for parkinson's disease treatment by bdnf-flag gene transfer through neurotensin polyplex to nigral dopamine neurons
03/13/2014WO2014037717A1 Compositions and methods relating to the treatment of diseases
03/13/2014WO2014037505A1 Probiotic bacteria as carrier for a helminth-derived immunomodulator for the treatment of inflammatory disorders
03/13/2014WO2014037390A1 Alpha-1-microglobulin for use in the treatment of mitochondria-related diseases
03/13/2014WO2014037373A1 Fusion proteins for treating a metabolic syndrome
03/13/2014WO2014037332A1 Inhibitors of alpha6 integrin/e-cadherin complex and their therapeutic and diagnostic use in cancer
03/13/2014WO2014036821A1 Novel compound with effects of thrombolysis, free radical scavenging and thrombus-targeting as well as preparation method and use thereof
03/13/2014WO2014036654A1 Compounds and methods for selectively targeting cancer stem cells
03/13/2014WO2014008366A3 Compositions comprising sulforaphane or a sulforaphane precursor and ursolic acid
03/13/2014WO2013184960A3 Chimeric fibroblast growth factor 23 proteins and methods of use
03/13/2014WO2013181461A3 Metal abstraction peptide with superoxide dismutase activity
03/13/2014WO2013173706A3 Huwentoxin-iv variants and methods of use
03/13/2014WO2012127352A8 Mia (melanoma inhibitory activity) inhibitors for detecting, preventing and curing vitiligo
03/13/2014WO2012119065A3 Antifungal agents and uses thereof
03/13/2014WO2012103391A3 Insescticidal composition and processes related thereto
03/13/2014US20140073687 Efficient protein expression in vivo using modified rna (mod-rna)
03/13/2014US20140073683 Modified small interfering rna molecules and methods of use
03/13/2014US20140073588 Glue composition for lung volume reduction
03/13/2014US20140073586 Compositions for the treatment of cancer, and methods for testing and using the same
03/13/2014US20140073583 Stable compositions of peptide epoxy ketones
03/13/2014US20140073580 Combinations of hdac inhibitors and proteasome inhibitors
03/13/2014US20140073579 SMAC Mimetic
03/13/2014US20140073578 Combination Therapy with Leukotoxin
03/13/2014US20140073571 Treatments for Gastrointestinal Disorders
03/13/2014US20140073570 Pharmaceutical composition and methods for peptide treatment
03/13/2014US20140073568 Administration of fgf9 for treatment of anxiety
03/13/2014US20140073566 Methods of using chimeric coiled-coil molecule
03/13/2014US20140073562 Nasal delivery
1 ... 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 ... 3163